| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |